245 filings
Page 3 of 13
8-K
a95gu4g0 dw
14 Dec 22
Other Events
8:29pm
424B5
mf29r8if
14 Dec 22
Prospectus supplement for primary offering
8:25pm
RW
fm7mbonfswh1lbc9 28p
12 Dec 22
Registration withdrawal request
8:00am
8-K
1ph3yx
7 Dec 22
Regulation FD Disclosure
4:15pm
8-K
qtpedo cmz1kdlep0w
6 Dec 22
BioVie Announces Positive Results for NE3107 in Parkinson’s and Alzheimer’s Phase 2 Trials
6:05am
8-K
a0nen
5 Dec 22
Other Events
9:47pm
424B5
dc5vof1zwyirukem zj
5 Dec 22
Prospectus supplement for primary offering
9:45pm
8-K
ifly m8lwbxa7sfgqv
10 Nov 22
Submission of Matters to a Vote of Security Holders
5:05pm
8-K
zvrp lk2mie2mgdik
4 Oct 22
BioVie Issues Letter to Shareholders
9:58pm
424B5
k99h5twpoa
30 Sep 22
Prospectus supplement for primary offering
5:15pm
8-K/A
948xexl hdt4962d
7 Sep 22
BioVie and Dr. Sheldon Jordan Jointly Announce Topline Results from an
5:17pm
8-K
6k3ey6vj5rqh1g7nl
7 Sep 22
BioVie and Dr. Sheldon Jordan Jointly Announce Topline Results from an
6:05am
8-K
lwq0zf 92x72prnxoc
31 Aug 22
Entry into a Material Definitive Agreement
5:15pm
424B5
78zsh8v1xj9q e85ctr
31 Aug 22
Prospectus supplement for primary offering
5:10pm
D
zg1rwkectg
25 Jul 22
$6M in equity / options / securities to be acquired, sold $6M, 1 investor
11:22am
DEF 14C
i1svu nilotyab86r
25 Jul 22
Information statement
7:00am